The Medical Management of Eosinophilic Esophagitis

Authors

  • Mary Sherlock, MB BCh BAO, PhD, FRCPC

DOI:

https://doi.org/10.58931/cait.2021.1322

Abstract

Eosinophilic esophagitis (EoE) was first recognised as a unique condition in the early 1990s. It was described by Alex Straumannwho identified 10 children with resistant ‘gastro-esophageal reflux disease (GERD) symptoms’ with typical endoscopic features and esophageal eosinophilia who achieved resolution of symptoms and esophageal eosinophilia with an elemental formula. While once a rare condition, EoE is being increasingly diagnosed worldwide, with an incidence rate estimated to be 5 to 10 per 100,000. While widely recognised as being a Th-2 inflammatory disorder, predominantly triggered by food allergens, there is a growing body of literature supporting the role of aeroallergens in the condition. Management of the condition involves close collaboration amongst gastroenterology and allergy specialists. At least half of affected patients will have other allergic disorders including allergic rhinitis, asthma, eczema and some will also have IgE-mediated food allergies. Workup and management of aeroallergen sensitivities is important as swallowed aeroallergens may be a contributing factor to eosinophilic esophagitis, with many patients noting a seasonal exacerbation in their symptoms.

Author Biography

Mary Sherlock, MB BCh BAO, PhD, FRCPC

Dr. Mary Sherlock is a pediatric gastroenterologist and Associate Professor at McMaster University, Hamilton. She obtained her medical degree from University College Dublin, Ireland. Her pediatric gastroenterology fellowship training was at The Hospital for Sick Children. She has a PhD in clinical epidemiology from the University of Toronto. Dr. Sherlock’s clinical and research interests are focused on pediatric eosinophilic esophagitis and pediatric inflammatory bowel disease. She is the clinical lead of the pediatric eosinophilic esophagitis clinic at McMaster Children’s Hospital.

References

Straumann A, Spichtin HP, Bernoulli R, et al. [Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings]. Schweiz Med Wochenschr. 1994 Aug 20;124(33):1419-29.

Arias A, Lucendo AJ. Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians. Expert Rev Gastroenterol Hepatol. 2020 nov;14(11):1069-82. doi:10.1080/17474124.2020.1806054

Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, et al. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology. 2020 May;158(6):1776-1786. doi:10.1053/j.gastro.2020.02.038

Dellon ES, Hirano I. Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology. 2018 Jan;154(2):319-32 e3. doi:10.1053/j.gastro.2017.06.067

Ram G, Lee J, Ott M, Brown-Whitehorn TF, Cianferoni A, Shuker M, et al. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol. 2015 Sep;115(3):224-8 e1. doi:10.1016/j.anai.2015.07.004

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018 Oct;155(4):1022-33 e10. doi:10.1053/j.gastro.2018.07.009

Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3-20 e6; quiz 1-2. doi:10.1016/j.jaci.2011.02.040

Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015 Oct;373(17):1640-8.

Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013 Apr;62(4):489-95. doi:10.1136/gutjnl-2011-301817

Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, Fernandez-Bermejo M, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011 Feb;9(2):110-7. doi:10.1016/j.cgh.2010.09.019

Hirano I, Furuta GT. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology. 2020 Mar;158(4):840-51. doi:10.1053/j.gastro.2019.09.052

Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, et al. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020 May;158(6):1789-810 e15. doi:10.1053/j.gastro.2020.02.039

Arias A, Gonzalez-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014 Jun;146(7):1639-48. doi:10.1053/j.gastro.2014.02.006

Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012 Jun;142(7):1451-9 e1; quiz e14-5. doi:10.1053/j.gastro.2012.03.001

Kagalwalla AF, Shah A, Li BU, Sentongo TA, Ritz S, Manuel-Rubio M, et al. Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):145-9. doi:10.1097/MPG.0b013e31821cf503

Lucendo AJ, Arias A, Gonzalez-Cervera J, Yague-Compadre JL, Guagnozzi D, Angueira T, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013 Mar;131(3):797-804. doi:10.1016/j.jaci.2012.12.664

Wechsler JB, Schwartz S, Arva NC, Kim KA, Chen L, Makhija M, et al. A Single Food Milk Elimination Diet Is Effective for Treatment of Eosinophilic Esophagitis in Children. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1748-1756.e11. doi:10.1016/j.cgh.2021.03.049

Molina-Infante J, Arias A, Alcedo J, Garcia-Romero R, Casabona-Frances S, Prieto-Garcia A, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. J Allergy Clin Immunol. 2018 Apr;141(4):1365-72. doi:10.1016/j.jaci.2017.08.038

Safroneeva E, Straumann A, Coslovsky M, Zwahlen M, Kuehni CE, Panczak R, et al. Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis. Gastroenterology. 2016 Mar;150(3):581-90 e4.

Molina-Infante J, Lucendo AJ. Dietary therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2018 Jul;142(1):41-7. doi:10.1016/j.jaci.2018.02.028

Mukkada VA, Haas A, Maune NC, Capocelli KE, Henry M, Gilman N, et al. Feeding dysfunction in children with eosinophilic gastrointestinal diseases. Pediatrics. 2010 Sep;126(3):e672-7. doi:10.1542/peds.2009-2227

Klinnert MD, Silveira L, Harris R, Moore W, Atkins D, Fleischer DM, et al. Health-related quality of life over time in children with eosinophilic esophagitis and their families. J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):308-16. doi:10.1097/MPG.0000000000000451

Lucendo AJ, Arias A, Molina-Infante J. Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2016;14(1):13-22 e1. doi:10.1016/j.cgh.2015.07.041

Gomez-Torrijos E, Garcia-Rodriguez R, Castro-Jimenez A, Rodriguez-Sanchez J, Mendez Diaz Y, Molina-Infante J. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther. 2016 Feb;43(4):534-40. doi:10.1111/apt.13496

Wen T, Dellon ES, Moawad FJ, Furuta GT, Aceves SS, Rothenberg ME. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol. 2015 Jan;135(1):187-97. doi:10.1016/j.jaci.2014.08.043

Gupta SK, Vitanza JM, Collins MH. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015 Jan;13(1):66-76 e3. doi:10.1016/j.cgh.2014.05.021

Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006 Nov;131(5):1381-91. doi:10.1053/j.gastro.2006.08.033

Murali AR, Gupta A, Attar BM, Ravi V, Koduru P. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials. J Gastroenterol Hepatol. 2016 Jun;31(6):1111-9. doi:10.1111/jgh.13281

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, et al. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Gastroenterology. 2019 Jul;157(1):65-73 e5. doi:10.1053/j.gastro.2019.03.014

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, et al. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology. 2019 Jul;157(1):74-86 e15. doi:10.1053/j.gastro.2019.03.025

Straumann A, Lucendo AJ, Miehlke S, Vieth M, Schlag C, Biedermann L, et al. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis. Gastroenterology. 2020 Nov;159(5):1672-85 e5. doi:10.1053/j.gastro.2020.07.039

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, et al. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology. 2019 Jul;157(1):74-86 e15. doi:10.1053/j.gastro.2019.03.025

Wang R, Hirano I, Doerfler B, Zalewski A, Gonsalves N, Taft T. Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis. Dig Dis Sci. 2018 Jul;63(7):1756-62. doi:10.1007/s10620-018-5045-0

Andreae DA, Hanna MG, Magid MS, Malerba S, Andreae MH, Bagiella E, et al. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Am J Gastroenterol. 2016 Aug;111(8):1187-97. doi:10.1038/ajg.2016.238

Dellon ES, Collins MH, Katzka DA, Mukkada VA, Falk GW, Morey R, et al. Long-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension. Clin Gastroenterol Hepatol. 2022 Jul;20(7):1488-1498.e11. doi:10.1016/j.cgh.2021.06.020

Issa-El-Khoury K, Kim H, Chan ES, Vander Leek T, Noya F. CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma. Allergy Asthma Clin Immunol. 2015 Mar;11(1):9. doi:10.1186/s13223-015-0075-z

Bose P, Kumar S, Nebesio TD, Li C, Hon EC, Atkins D, et al. Adrenal Insufficiency in Children With Eosinophilic Esophagitis Treated With Topical Corticosteroids. J Pediatr Gastroenterol Nutr. 2020 Mar;70(3):324-329. doi:10.1097/MPG.0000000000002537

Ahmet A, Benchimol EI, Goldbloom EB, Barkey JL. Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2016 Oct;12:49. doi:10.1186/s13223-016-0154-9

Golekoh MC, Hornung LN, Mukkada VA, Khoury JC, Putnam PE, Backeljauw PF. Adrenal Insufficiency after Chronic Swallowed Glucocorticoid Therapy for Eosinophilic Esophagitis. J Pediatr. 2016 Mar;170:240-5. doi:10.1016/j.jpeds.2015.11.026

Hsu S, Wood C, Pan Z, Rahat H, Zeitler P, Fleischer D, et al. Adrenal Insufficiency in Pediatric Eosinophilic Esophagitis Patients Treated with Swallowed Topical Steroids. Pediatr Allergy Immunol Pulmonol. 2017 Sep;30(3):135-140. doi:10.1089/ped.2017.0779

Runge TM, Eluri S, Cotton CC, Burk CM, Woosley JT, Shaheen NJ, et al. Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype. Am J Gastroenterol. 2016 Feb;111(2):206-13. doi:10.1038/ajg.2015.399

Friedlander JA, DeBoer EM, Soden JS, Furuta GT, Menard-Katcher CD, Atkins D, et al. Unsedated transnasal esophagoscopy for monitoring therapy in pediatric eosinophilic esophagitis. Gastrointest Endosc. 2016 Feb;83(2):299-306 e1. doi:10.1016/j.gie.2015.05.044

Nguyen N, Lavery WJ, Capocelli KE, Smith C, DeBoer EM, Deterding R, et al. Transnasal Endoscopy in Unsedated Children With Eosinophilic Esophagitis Using Virtual Reality Video Goggles. Clin Gastroenterol Hepatol. 2019 Nov;17(12):2455-62. doi:10.1016/j.cgh.2019.01.023

Kadayifci A, Atar M, Parlar S, et al. Transnasal endoscopy is preferred by transoral endoscopy experienced patients. J Gastrointestin Liver Dis. 2014 Mar;23(1):27-31.

Scherer C, Sosensky P, Schulman-Green D, Levy M, Smith C, Friedlander J, et al. Pediatric Patients’ and Parents’ Perspectives of Unsedated Transnasal Endoscopy in Eosinophilic Esophagitis: A Qualitative Descriptive Study. J Pediatr Gastroenterol Nutr. 2021 Apr 1;72(4):558-62. doi:10.1097/MPG.0000000000003029

Ackerman SJ, Kagalwalla AF, Hirano I, Gonsalves N, Katcher PM, Gupta S, et al. One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis. Am J Gastroenterol. 2019 Oct;114(10):1614-25. doi:10.14309/ajg.0000000000000371

Katzka DA, Smyrk TC, Alexander JA, Geno DM, Beitia RA, Chang AO, et al. Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study. Am J Gastroenterol. 2017 Oct;112(10):1538-44. doi:10.1038/ajg.2017.244

The Medical Management of Eosinophilic Esophagitis

Published

2021-12-01

How to Cite

1.
Sherlock M. The Medical Management of Eosinophilic Esophagitis. Can Allergy Immunol Today [Internet]. 2021 Dec. 1 [cited 2024 Sep. 16];1(3):26–31. Available from: https://canadianallergyandimmunologytoday.com/article/view/1-3-sherlock

Issue

Section

Articles